ZNF567 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.552400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.539400E-01
Normal-vs-Stage2
7.583500E-02
Normal-vs-Stage3
3.828000E-02
Normal-vs-Stage4
7.697000E-01
Stage1-vs-Stage2
5.393800E-01
Stage1-vs-Stage3
1.010990E-01
Stage1-vs-Stage4
4.172000E-01
Stage2-vs-Stage3
1.124790E-01
Stage2-vs-Stage4
1.139450E-01
Stage3-vs-Stage4
1.506340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.059500E-02
Normal-vs-AfricanAmerican
2.857000E-01
Normal-vs-Asian
1.801810E-01
Caucasian-vs-AfricanAmerican
6.543600E-01
Caucasian-vs-Asian
6.997400E-01
AfricanAmerican-vs-Asian
6.164400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.140100E-02
Normal-vs-Female
6.623900E-02
Male-vs-Female
4.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.342800E-01
Normal-vs-Age(41-60Yrs)
2.237200E-01
Normal-vs-Age(61-80Yrs)
4.524300E-02
Normal-vs-Age(81-100Yrs)
2.842400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.281600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.180000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.493600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.822900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.780300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.336400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.851700E-02
Normal-vs-Daily Drinker
9.357400E-03
Normal-vs-Weekly Drinker
9.573800E-02
Normal-vs-Occasional Drinker
2.000200E-01
Normal-vs-Social Drinker
2.851800E-01
Non Drinker-vs-Daily Drinker
4.483800E-01
Non Drinker-vs-Weekly Drinker
5.685400E-01
Non Drinker-vs-Occasional Drinker
4.583800E-02
Non Drinker-vs-Social Drinker
7.133900E-02
Daily Drinker-vs-Weekly Drinker
2.337200E-01
Daily Drinker-vs-Occasional Drinker
8.401400E-03
Daily Drinker-vs-Social Drinker
1.876450E-02
Weekly Drinker-vs-Occasional Drinker
2.527200E-01
Weekly Drinker-vs-Social Drinker
3.059200E-01
Occasional Drinker-vs-Social Drinker
9.742600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.039790E-01
Normal-vs-Grade 2
2.428100E-02
Normal-vs-Grade 3
2.339800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.904200E-01
Grade 1-vs-Grade 3
5.109200E-01
Grade 1-vs-Grade 4
1.039790E-01
Grade 2-vs-Grade 3
6.446800E-01
Grade 2-vs-Grade 4
2.428100E-02
Grade 3-vs-Grade 4
2.339800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.600200E-02
Normal-vs-NonDiabetic
6.723900E-02
Diabetic-vs-NonDiabetic
3.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.056100E-02
Normal-vs-NoPancreatitis
6.886100E-02
Pancreatitis-vs-NoPancreatitis
2.968000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.139900E-02
Normal-vs-N1
7.128200E-02
N0-vs-N1
6.713600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.357000E-01
Normal-vs-TP53-NonMutant
2.194200E-01
TP53-Mutant-vs-TP53-NonMutant
8.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
